Lactulosa Biomedica

Lactulose, the active ingredient in Lactulosa Biomedica, is an osmotic laxative presented as an oral formulation for oral use. It works by drawing water into the colon and reducing ammonia absorption, thereby relieving constipation and managing hepatic encephalopathy in adult patients.

GNH USA supplies Lactulosa Biomedica as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, ensuring quality and regulatory compliance across global markets. The company adheres to strict manufacturing standards and provides reliable logistics for timely delivery.

Lactulose is used to treat conditions related to bowel motility and ammonia metabolism.

- Constipation: softens stool and promotes regular bowel movements by increasing colonic water content. - Chronic constipation: provides sustained symptom relief for patients with long‑term bowel irregularities. - Hepatic encephalopathy: lowers blood ammonia levels, helping improve mental status in patients with liver disease.

Lactulose may be associated with several adverse reactions, ranging from mild to serious.

Common Side Effects: - Abdominal cramping: discomfort due to increased colonic activity. - Flatulence: excess gas production from bacterial fermentation. - Diarrhea: loose stools from osmotic water influx. - Nausea: mild upset stomach. - Bloating: sensation of abdominal fullness. - Thirst: increased fluid loss.

Serious or Rare Side Effects: - Severe dehydration: excessive fluid loss leading to low blood volume. - Electrolyte disturbances: notably hypokalemia from prolonged diarrhea. - Allergic reactions: rash, itching, or angioedema. - Colonic perforation: rare but life‑threatening injury to the bowel wall.

Lactulose should be used with caution in specific clinical situations.

- Assess renal function: monitor patients with renal impairment for electrolyte changes. - Evaluate liver status: use cautiously in severe hepatic failure. - Monitor fluid balance: watch for dehydration, especially in elderly patients. - Adjust dose in pediatric patients only if prescribed by a qualified clinician. - Avoid in patients with known hypersensitivity to lactulose. - Store at ambient temperature: keep in the original container, protect from moisture.

Lactulose can interact with other medicines, requiring attention to avoid reduced efficacy or increased risk.

Major Interactions (Avoid): - Antidiarrheal agents (e.g., loperamide): may counteract lactulose’s laxative effect. - Antibiotics that alter gut flora (e.g., broad‑spectrum agents): can diminish lactulose metabolism and efficacy.

Moderate Interactions (Monitor Closely): - Mineral supplements (e.g., magnesium, calcium): may enhance osmotic activity and increase risk of diarrhea. - Diabetes medications: monitor blood glucose as lactulose fermentation can affect carbohydrate balance. - Proton‑pump inhibitors: may modify gastric pH and affect lactulose breakdown.